NEWOMICS INC.

Emeryville, CA · CIK 0001827643 · Medtech · Private

Nanoflow LC-picoelectrospray ionization mass spectrometry system with microfabricated multinozzle emitters for top-down proteomics analysis

newomics.com →
Grants
$17M
20 awards
Sector median: 1
Raised
$3.9M
1 Form D · Oct 2020
71 months since last filing
Contracts
$330K
2 awards · Health and Human S
#415 of 4531 in medtech
Patents
15
3 granted · 12 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Health and Human Services · Igf::ot::igf Omics-chips For Ctc Isolation And Molecular Analysis$300,000
Federal grantDepartment of Health and Human Services · Phase II · Microfluidic Chips for Biomonitoring$750,000
Federal grantDepartment of Health and Human Services · Phase I · AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease$349,999
Federal grantDepartment of Health and Human Services · Phase I · Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics$341,623
Federal grantDepartment of Health and Human Services · Phase I · Senescence-Chips for Radiation Biodosimetry$299,999
Federal grantDepartment of Health and Human Services · Phase II · Omics-Based Assays for Screening Chemical Toxicity Using Stem Cells$750,000
Federal grantDepartment of Health and Human Services · Phase II · Microfluidic Chips for Biomonitoring$746,462
Federal grantDepartment of Health and Human Services · Phase II · Ultrahigh-throughput Identification of Molecular Targets of Natural Products$688,748
Federal grantDepartment of Health and Human Services · Phase II · Omics-Based Assays for Screening Chemical Toxicity Using Stem Cells$750,000
Federal grantDepartment of Health and Human Services · Phase II · Ultrahigh-throughput Identification of Molecular Targets of Natural Products$811,252
Federal grantDepartment of Health and Human Services · Phase II · Omics-Based Assays for Screening Chemical Toxicity Using Stem Cells$2,500
Federal grantDepartment of Health and Human Services · Phase II · AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease$749,999
Federal grantDepartment of Health and Human Services · Phase II · Senescence-Chips for Radiation Biodosimetry$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Senescence-Chips for Radiation Biodosimetry$2,994,730
Federal grantDepartment of Health and Human Services · Phase II · AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease$749,999
Federal grantDepartment of Health and Human Services · Phase II · Senescence-Chips for Radiation Biodosimetry$997,365
Private capital raisedForm D · SEC$3,924,995
Federal grantDepartment of Health and Human Services · Phase II · Senescence-Chips for Radiation Biodosimetry$997,365
Federal grantDepartment of Health and Human Services · Phase II · Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics$865,365
Federal grantDepartment of Health and Human Services · Phase II · Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics$1,730,730
Federal grantDepartment of Health and Human Services · Phase II · Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics$865,365
Federal contractDepartment of Health and Human Services · Electrospray Ionization Source That Will Increase Ionization Efficiency$30,286
Federal grantDepartment of Health and Human Services · Phase II · Multispray Technology for Studying Biomolecular Interactions$1,000,000
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
412TELE-STETHOSCOPE INC.$338K—
413CLARIX IMAGING CORP$336K—
414AIDAR HEALTH, INC$336K—
415NEWOMICS INC.$330K$3.9M
416INSIGHTEC LTD$309K$300M
417AEROPHASE, INC.$304K—
418CORGENIX MEDICAL CORPORATION$301K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Ted HouDirector
  • Pan MaoDirector
  • Patrick ScannonDirector
  • Daojing WangDirector · Executive Officer

Patents

USPTO · 3 granted of 15
  • Methods And Systems For Sorting Biological Particlesapplication
  • Method For Diagnosing Diseasesapplication
  • Methods And Systems For Sorting Biological Particlesapplication
  • Methods And Systems For Diagnosing Diseasesgranted
  • Methods And Systems For Separating Biological Particlesapplication
  • Methods And Systems For Biomonitoringgranted
  • Methods And Systems For Diagnosing Diseasesgranted
  • Methods And Systems For Diagnosing Diseasesapplication
  • Methods And Systems For Sorting Biological Particlesapplication
  • Methods And Systems For Separating Biological Particlesapplication
  • Methods And Systems For Cell-based Diagnosis And Therapiesapplication
  • Methods And Systems For Biomonitoringapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.